Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EORTC 1205: Surgery and Chemotherapy in Early Mesothelioma
NCT02436733Phase 2Unknown
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Sep 2016
- Primary completion
- Jul 2023
- Modality
- Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pemetrexed, Cisplatin micelle injection (HA132) in malignant pleural mesothelioma (MPM), sponsored by European Organisation for Research and Treatment of Cancer. Status: unknown.
02
Drugs
pemetrexedCisplatin micelle injection (HA132)
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT02436733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02436733.